|1.||Strongin, Robert M: 3 articles (01/2011 - 01/2008)|
|2.||Lange, Thilo S: 3 articles (01/2011 - 01/2008)|
|3.||Singh, Rakesh K: 3 articles (01/2011 - 01/2008)|
|4.||Kim, Kyu Kwang: 3 articles (01/2011 - 01/2008)|
|5.||Brard, Laurent: 3 articles (01/2011 - 01/2008)|
|6.||Moore, Richard G: 1 article (01/2011)|
|7.||Gust, Ronald: 1 article (11/2010)|
|8.||Hille, Annegret: 1 article (11/2010)|
|9.||McCourt, Carolyn: 1 article (01/2009)|
|10.||Luisi, Brian S: 1 article (01/2009)|
|1.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2009 - "Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model."
01/01/2008 - "In this pioneer study to the biological activity of organometallic compound Iron(III)-salophene (Fe-SP) the specific effects of Fe-SP on viability, morphology, proliferation, and cell-cycle progression on platinum-resistant ovarian cancer cell lines were investigated. "
01/01/2008 - "Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells."
01/01/2011 - "The objective of the present study was to investigate the specific effects of Iron(III)-salophene (Fe-SP) on viability, morphology, proliferation, cell cycle progression, ROS generation and pro-apoptotic MAPK activation in neuroblastoma (NB) cells. "
01/01/2011 - "Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation."
|4.||Breast Neoplasms (Breast Cancer)